OmniCar Holding AB held its annual general meeting today, 16 June 2023. The main resolutions passed at the meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the annual general meeting and the complete proposals, which are available on the companyâs website.
Adoption of the profit and loss statements and the balance sheets, disposition of the companyâs earnings
The annual general meeting resolved to adopt the profit and loss statements and the balance sheet for the parent company as well as the consolidated
Lars Gusch, CEO of Pharmacolog i Uppsala AB (publ) presented the companyâs new strategic direction at SmÃ¥bolagsdagarna, June 12th, 2023.
Pharmacolog paves the way for strong commercial development. By broadening the distribution network and introducing a SaaS model to lower the initial investment, moreÂ hospitalsÂ canÂ implementÂ qualityÂ controlÂ ofÂ compounded pharmaceuticalsÂ andÂ therebyÂ increaseÂ patientÂ safety.Â The live streamed event was arranged by Aktiespararna and the presentation (in Swedish) has been made available on the company website https://pharmacolog.com/investor-relations-2/.
The hygiene and health company Essity divests its operations in Russia. Essity has signed an agreement with a buyer and the transaction has now been approved by the Russian authorities. The transaction is expected to be finalized during the second quarter of 2023.
Essity began work in April 2022 to exit the Russian market and in 2022 an impairment was carried out of the companyâs assets in Russia of approximately SEK 1.7bn. In 2022, Essityâs net sales in Russia amounted to approximately 2% of the Groupâs total net sales.Â
The total earnings impact will be reported when the transaction is
Stockholm, Sweden â June 8[th], 2023 – iCellate Medical has closed a successful round of financing, raising 20 MSEK from a combination of existing and new investors. iCellate develops cancer tests for early detection, treatment selection, and hereditary cancer risk.
iCellate is a privately held life sciences company, spearheading the industry in cancer profiling. Through liquid biopsy tests, the analysis of tumor-derived material in the blood or saliva, iCellate paves the way for precision medicine to reach more patients. Ongoing clinical studies investigating iCellateâs CTC-based technology,
What are the latest financial developments?
We are proud to introduce MyntNews, a comprehensive news and information platform that provides traders and investors with accurate, unbiased, and objective news With the market rebounding, now is the time to invest in your future. If you want to stay ahead in trading, MyntNews can assist you in achieving this. MyntNews is an element of the MyntExchange trading platform and MyntEcosystem, which is dedicated to delivering personalized news tailored to your interests and preferences. Comprehensive and up-to-date information is essential for
CHOSA Oncology AB publishes results from clinical phase 2 trial of liposomal formulation in breast cancer, using predictive marker for cisplatin
[En bild som visar text, skÃ¤rmbild, Teckensnitt, nummer Automatiskt genererad beskrivning] Â CEO Peter Buhl comments: âCHOSA presents these important findings that have crystallized by deep clinical knowledge and years of dedication to developing LiPlaCis and its response prediction test DRPâ. Â We welcome interaction and look forward to discussing this at the ASCO poster session that opens today: Â Abstract number and title:Â 3130;Â Predictive biomarker for cisplatin in prospective phase 2 of liposomal cisplatin in metastatic breast cancer
YIT selected as Prysmian Group Finland’s alliance partner for the Prysmian Groups cable tower construction project in Kirkkonummi
YIT Corporation Investor News 1 June 2023 at 07:00
Prysmian Group Finland Oy has selected YIT as its implementation phase partner for the construction of the Prysmian tower in Kirkkonummi. The implementation phase will continue the cooperation from the development phase, transforming the project into an alliance project. The estimated total value of the construction project is approximately EUR 65 million. The contract will be entered in the order book of the second quarter of the year. The building is to become a production facility of high-voltage submarine cables and, at 185 metres,
Forensic experts are developing a new system which could revolutionise how evidence is used in domestic violence and sexual assault cases.
Staffordshire UniversityÂ (https://www.staffs.ac.uk/research/centres-and-groups/centre-for-crime-justice-and-security), the Forensic Capability NetworkÂ (https://www.fcn.police.uk/) (FCN) and SpectriconÂ (https://spectricon.com/) are leading a project which aims to improve the way forensic evidence is processed in criminal cases involving violence against women and girls (VAWG). The end product will be a new system that dramatically improves the way these
CITYCON OYJ Corporate Press Release 25 May 2023 at 11:30 hours
[image] Citycon has updated its sustainability strategy for the coming period including focus areas, objectives and measurements. The updated sustainability strategy enables the company to work effectively on multiple areas towards its ambitious goals for 2030. Citycon has received recognition for its efforts to reduce the greenhouse gas emissions by being named among Europeâs Climate Leader companies for the third consecutive year by Financial Times and Statista. To underline its commitment to the long-term sustainability
The Norwegian Minister of Petroleum and Energy, Terje Aasland visited Elkem Salten on Monday 22 May. Elkemâs supplies of critical raw materials to the green transition were among the topics presented by plant manager Ove SÃ¸rdahl.
Elkem Salten, located in Nordland county in Norway, is one of the worldâs largest, most modern and most sustainable silicon plants exporting silicon and microsilica products worldwide. Silicon metal is ranked as one of the critical raw materials for the EU, and Norway is Europeâs largest producer. The production of silicon is energy intensive, and Elkem more than